On Aug. 30, 2023, the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury issued the proposed rule titled “Requirements Related to the Mental Health Parity and Addiction Equity Act. AMCP submitted comments in response to the proposed rule on Oct. 17.
With October devoted to National Pharmacy Awareness, AMCP CEO Susan Cantrell talks about the outstanding efforts of managed care pharmacists across the United States in her latest blog.
The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC) today announced that it has been awarded a $1.4 million grant from the Food & Drug Administration (FDA) to enable biosimilar research.
The rebate system is an important lever for ensuring the affordability of prescription medications and health care premiums for Americans. AMCP supports the use of a rebate system as one of many levers to help to control drug costs.
Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
Schizophrenia is a mental disorder that can be characterized by disruptions in a person's thought process, perception, responsiveness, and interactivity.
"Biosimilars for Employer Consultants" was created to provide background information on biosimilars and to provide considerations for consultants to discuss with their employer clients.
September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
On August 21, 2023, CMS Issued the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025. The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program.